U.S. regulators give full approval of Pfizer-BioNTech's COVID-19 vaccine

HEALTH–CORONAVIRUS/USA-PFIZER

The U.S. gave full approval to Pfizer-BioNTech's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus variant yet.



Comments

Popular posts from this blog